 New York, New York--Newsfile Corp. - August 12, 2020 - The following statement is being issued by Levi Korsinsky, LLP:To: All Persons or Entities who purchased Cellular Biomedicine Group, Inc. Cellular Biomedicine or the Company NASDAQ: CBMG stock prior to August 12, 2020.You are hereby notified that Levi Korsinsky, LLP has commenced an investigation into the fairness of the sale of Cellular Biomedicine to a consortium that includes members of Cellular ... 